2018
Impact of bariatric surgery in patients with HIV infection
Sharma P, McCarty TR, Ngu JN, O'Donnell M, Njei B. Impact of bariatric surgery in patients with HIV infection. AIDS 2018, 32: 1959-1965. PMID: 30157083, PMCID: PMC6126912, DOI: 10.1097/qad.0000000000001915.Peer-Reviewed Original ResearchConceptsBariatric surgeryIncidence risk ratioMorbid obesityRespiratory failureObese patientsRenal failureClinical outcomesUnited States Nationwide Inpatient Sample databaseNationwide Inpatient Sample databaseObese HIV patientsLife-threatening morbidityUrinary tract infectionWeight loss surgeryRelevant clinical outcomesLength of stayRates of obesityHospital mortalityHIV patientsThromboembolic eventsSecondary outcomesTract infectionsHIV infectionPrimary outcomeMultivariable analysisDischarge diagnosis
2017
Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004–2014
Sharma P, McCarty TR, Njei B. Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004–2014. Obesity Surgery 2017, 28: 1015-1024. PMID: 29047047, DOI: 10.1007/s11695-017-2959-0.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBariatric SurgeryDatabases, FactualFemaleHospital CostsHospital MortalityHospitalizationHumansIncidenceInflammatory Bowel DiseasesInpatientsMaleMiddle AgedMorbidityObesity, MorbidPostoperative ComplicationsPrognosisTreatment OutcomeUnited StatesYoung AdultConceptsInflammatory bowel diseaseIncidence risk ratioObese IBD patientsBariatric surgeryMorbid obesityIBD patientsRenal failureBowel diseaseClinical outcomesUnited States National Inpatient Sample (NIS) databaseNational Inpatient Sample databaseOutcomes of patientsLength of stayPaucity of dataHospital mortalityThromboembolic eventsObese patientsSecondary outcomesHospitalized patientsPrimary outcomeMultivariable analysisDischarge diagnosisFistula formationHospitalization costsRisk ratioImpact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012
McCarty TR, Echouffo-Tcheugui JB, Lange A, Haque L, Njei B. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004–2012. Surgery For Obesity And Related Diseases 2017, 14: 74-80. PMID: 29055669, DOI: 10.1016/j.soard.2017.09.511.Peer-Reviewed Original ResearchConceptsNonalcoholic fatty liver diseasePrior bariatric surgeryBariatric surgeryFatty liver diseaseIncidence risk ratioNAFLD patientsMorbid obesityRenal failureClinical outcomesLiver diseaseMyocardial infarctionRisk ratioNationwide Inpatient Sample AnalysisNationwide Inpatient Sample databaseObese NAFLD patientsOutcomes of patientsBariatric surgery proceduresMorbidly obese individualsPopulation-based dataHospital mortalityHospital morbidityInpatient mortalitySecondary outcomesHospitalized patientsPrimary outcomeEarly transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding
Njei B, McCarty TR, Laine L. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding. Journal Of Gastroenterology And Hepatology 2017, 32: 852-858. PMID: 27624167, PMCID: PMC5350067, DOI: 10.1111/jgh.13593.Peer-Reviewed Original ResearchConceptsEarly transjugular intrahepatic portosystemic shuntTransjugular intrahepatic portosystemic shuntAcute esophageal variceal bleedingEsophageal variceal bleedingIntrahepatic portosystemic shuntVariceal bleedingUS patientsPortosystemic shuntNationwide Inpatient Sample databaseHospital mortality rateUS clinical practiceDays of hospitalizationFurther bleedingHospital deathRecurrent bleedingEndoscopic therapyInpatient mortalityPreventive therapySecondary outcomesHepatic encephalopathyPrimary outcomeHigh riskHospital reductionMortality ratePatients
2016
Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis
Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. Journal Of Gastroenterology And Hepatology 2016, 31: 1141-1146. PMID: 26749521, PMCID: PMC4885788, DOI: 10.1111/jgh.13289.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAge FactorsAgedCarcinoma, Squamous CellEarly Detection of CancerEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagectomyFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoplasm StagingPredictive Value of TestsProportional Hazards ModelsRetrospective StudiesRisk FactorsSEER ProgramSurvival RateTime FactorsTreatment OutcomeUnited StatesConceptsSquamous cell carcinomaEsophageal cancerEsophageal adenocarcinomaMedian survivalBetter long-term survival outcomesLong-term survival outcomesOverall median survivalEnd Results (SEER) databaseProportion of patientsSEER database analysisSignificant survival improvementProportional hazards regressionEsophageal cancer survivalLong-term survivalIndependent mortality factorsLocalized diseaseCurative stageSurgical treatmentSurvival improvementHazards regressionResults databaseSurvival outcomesCell carcinomaTreatment modalitiesCancer survival
2015
Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Rustagi T, Njei B. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2015, 44: 859-867. PMID: 26168316, PMCID: PMC4824288, DOI: 10.1097/mpa.0000000000000326.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisNonsteroidal anti-inflammatory drugsAnti-inflammatory drugsCholangiopancreatography pancreatitisRectal administrationIncidence of PEPRisk of PEPPreventing Post-Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreatic duct injectionOddi dysfunctionSubgroup analysisDuct injectionPatientsTreatment typeRelevant studiesERCPPancreatitisSignificant reductionAdministrationDrugsEfficacySignificant benefitsRiskPlaceboSphincter
2014
Risk of comorbidities and outcomes in patients with lower gastrointestinal bleeding-a nationwide study
Venkatesh PG, Njei B, Sanaka MR, Navaneethan U. Risk of comorbidities and outcomes in patients with lower gastrointestinal bleeding-a nationwide study. International Journal Of Colorectal Disease 2014, 29: 953-960. PMID: 24913253, PMCID: PMC4823646, DOI: 10.1007/s00384-014-1915-x.Peer-Reviewed Original ResearchConceptsLower gastrointestinal bleedingOutcomes of patientsYears of ageMortality rateGastrointestinal bleedingPrevalence of comorbiditiesRisk of comorbiditiesNumber of comorbiditiesPrimary discharge diagnosisCongestive heart failureImpact of comorbiditiesClinical Modification codesHealth care utilizationIdentification of comorbiditiesRisk of mortalityRisk-adjustment toolLogistic regression modelsHospital mortalityMore comorbiditiesComorbid illnessesElixhauser indexHospital stayRenal failureHeart failureOverall mortalitySofosbuvir-ribavirin duo for chronic hepatitis C.
Njei B. Sofosbuvir-ribavirin duo for chronic hepatitis C. Connecticut Medicine 2014, 78: 355-6. PMID: 25672064, PMCID: PMC4821410.Peer-Reviewed Original Research